Based on the information from the GEO online database (GSE40231) using the patient-derived tissue samples from the atherosclerotic arterial walls and non-atherosclerotic arterial walls of patients with coronary artery disease, we found that the mRNA expression levels of ApoL1 were significantly elevated in atherosclerotic arterial walls, suggesting that ApoL1 may be a risk gene associated with atherosclerotic cardiovascular disease (Fig. 1A). Here, APOL1 is linked to coronary artery disorder.